John C. Paschold

1.2k total citations · 1 hit paper
7 papers, 847 citations indexed

About

John C. Paschold is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John C. Paschold has authored 7 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Pathology and Forensic Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John C. Paschold's work include Lung Cancer Treatments and Mutations (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Genomics and Diagnostics (2 papers). John C. Paschold is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Genomics and Diagnostics (2 papers). John C. Paschold collaborates with scholars based in United States and United Kingdom. John C. Paschold's co-authors include Norbert Avril, Heloisa P. Soares, Gary H. Lyman, Dominique Delbeke, Barry A. Siegel, R. Edward Coleman, Benjamin Djulbegović, Anthony F. Shields, Val J. Lowe and Lawrence H. Einhorn and has published in prestigious journals such as Journal of Clinical Oncology, Fertility and Sterility and Journal of Nuclear Medicine.

In The Last Decade

John C. Paschold

5 papers receiving 833 citations

Hit Papers

Recommendations on the Use of 18F-FDG PET in Oncology 2008 2026 2014 2020 2008 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Paschold United States 3 522 243 171 119 88 7 847
Amir H. Khandani United States 18 305 0.6× 377 1.6× 215 1.3× 82 0.7× 45 0.5× 59 759
F. Cachin France 15 294 0.6× 137 0.6× 180 1.1× 173 1.5× 36 0.4× 70 716
Hani Ashamalla United States 17 322 0.6× 371 1.5× 276 1.6× 142 1.2× 41 0.5× 70 1.0k
Quan‐Sing Ng Singapore 13 237 0.5× 251 1.0× 256 1.5× 155 1.3× 68 0.8× 17 770
Neil K. Taunk United States 18 329 0.6× 295 1.2× 278 1.6× 190 1.6× 51 0.6× 102 985
K. Pigott United Kingdom 14 455 0.9× 509 2.1× 337 2.0× 120 1.0× 33 0.4× 24 863
D. Cobben Netherlands 15 779 1.5× 584 2.4× 253 1.5× 157 1.3× 40 0.5× 41 1.3k
John O. Olsen United States 13 348 0.7× 293 1.2× 227 1.3× 213 1.8× 42 0.5× 42 877
G. Jerusalem Belgium 4 396 0.8× 236 1.0× 132 0.8× 78 0.7× 22 0.3× 8 642
Arndt‐Christian Müller Germany 21 390 0.7× 659 2.7× 184 1.1× 190 1.6× 72 0.8× 71 1.1k

Countries citing papers authored by John C. Paschold

Since Specialization
Citations

This map shows the geographic impact of John C. Paschold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Paschold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Paschold more than expected).

Fields of papers citing papers by John C. Paschold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Paschold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Paschold. The network helps show where John C. Paschold may publish in the future.

Co-authorship network of co-authors of John C. Paschold

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Paschold. A scholar is included among the top collaborators of John C. Paschold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Paschold. John C. Paschold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Butrynski, James E., John C. Paschold, Patrick J. Ward, et al.. (2024). Biomarker testing in early-stage NSCLC: Results from the MYLUNG Consortium.. Journal of Clinical Oncology. 42(16_suppl). 8047–8047. 1 indexed citations
2.
Butrynski, James E., John C. Paschold, Patrick J. Ward, et al.. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.. Journal of Clinical Oncology. 41(16_suppl). 9109–9109. 3 indexed citations
3.
Jotte, Robert M., Alexander I. Spira, David Waterhouse, et al.. (2021). P60.13 MYLUNG Consortium: Molecularly Informed Lung Cancer Treatment in a Community Cancer Network. Pragmatic Prospective RWR Study. Journal of Thoracic Oncology. 16(10). S1170–S1171.
4.
Fletcher, James, Benjamin Djulbegović, Heloisa P. Soares, et al.. (2014). Recommendations on the Use of 18F-FDG PET in Oncology.
5.
Fletcher, James, Benjamin Djulbegović, Heloisa P. Soares, et al.. (2008). Recommendations on the Use of 18F-FDG PET in Oncology. Journal of Nuclear Medicine. 49(3). 480–508. 790 indexed citations breakdown →
6.
Cline, J. Mark, et al.. (1996). Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertility and Sterility. 65(5). 1031–1035. 52 indexed citations
7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026